Zi Long Qian
Chief Executive Officer presso SHENZHEN KINGSINO TECHNOLOGY CO.,LTD.
Patrimonio netto: 204 376 $ in data 31/03/2024
Profilo
Zi Long Qian is currently the Director at Wuhan Huayang Animal Pharmaceutical Co., Ltd.
and the General Manager at Shenzhen Kingsino Technology Co., Ltd.
He has an undergraduate degree from China University of Geosciences and an MBA from Sun Yat-Sen University.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
26/08/2023 | 292 500 ( 0.05% ) | 204 376 $ | 31/03/2024 |
Posizioni attive di Zi Long Qian
Società | Posizione | Inizio |
---|---|---|
SHENZHEN KINGSINO TECHNOLOGY CO.,LTD. | Chief Executive Officer | 28/10/2022 |
Wuhan Huayang Animal Pharmaceutical Co., Ltd.
Wuhan Huayang Animal Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Wuhan Huayang Animal Pharmaceutical Co., Ltd. is a private company that manufactures and sells veterinary drugs, aquatic feed drug additives, and aquaculture fertilizer. The company is based in Wuhan, China. Wuhan Huayang Animal Pharmaceutical Co. was acquired by Wuhan Huayang Animal Pharmaceutical Co. Ltd. /Sun/ from Shenzhen Kingsino Technology Co., Ltd. on April 16, 2022 for $24.21 million. The Chinese company was founded in 2000. The CEO is Jin Lin Zhang. | Director/Board Member | - |
Formazione di Zi Long Qian
China University of Geosciences | Undergraduate Degree |
Sun Yat-Sen University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
SHENZHEN KINGSINO TECHNOLOGY CO.,LTD. | Process Industries |
Aziende private | 1 |
---|---|
Wuhan Huayang Animal Pharmaceutical Co., Ltd.
Wuhan Huayang Animal Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Wuhan Huayang Animal Pharmaceutical Co., Ltd. is a private company that manufactures and sells veterinary drugs, aquatic feed drug additives, and aquaculture fertilizer. The company is based in Wuhan, China. Wuhan Huayang Animal Pharmaceutical Co. was acquired by Wuhan Huayang Animal Pharmaceutical Co. Ltd. /Sun/ from Shenzhen Kingsino Technology Co., Ltd. on April 16, 2022 for $24.21 million. The Chinese company was founded in 2000. The CEO is Jin Lin Zhang. | Health Technology |
- Borsa valori
- Insiders
- Zi Long Qian